Cargando…

Prediction of exposure-driven myelotoxicity of continuous infusion 5-fluorouracil by a semi-physiological pharmacokinetic–pharmacodynamic model in gastrointestinal cancer patients

PURPOSE: To describe 5-fluorouracil (5FU) pharmacokinetics, myelotoxicity and respective covariates using a simultaneous nonlinear mixed effect modelling approach. METHODS: Thirty patients with gastrointestinal cancer received 5FU 650 or 1000 mg/m(2)/day as 5-day continuous venous infusion (14 of wh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arshad, Usman, Ploylearmsaeng, Su-arpa, Karlsson, Mats O., Doroshyenko, Oxana, Langer, Dorothee, Schömig, Edgar, Kunze, Sabine, Güner, Semih A., Skripnichenko, Roman, Ullah, Sami, Jaehde, Ulrich, Fuhr, Uwe, Jetter, Alexander, Taubert, Max
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125253/ https://www.ncbi.nlm.nih.gov/pubmed/32152679 http://dx.doi.org/10.1007/s00280-019-04028-5

Ejemplares similares

Clinical Pharmacokinetics and Pharmacodynamics of Cefiderocol
por: Bilal, Muhammad, et al.
Publicado: (2021)

Stem cell assays in the evaluation of myelotoxicity
por: Mangalik, Aroop, et al.
Publicado: (1981)

Assessment of myelotoxicity caused by environmental chemicals.
por: Boorman, G A, et al.
Publicado: (1982)

Evaluation of Myelotoxicity in Dietary Restricted Rats
por: Miyata, Hiroto, et al.
Publicado: (2009)

Prevention by Chitosan of Myelotoxicity, Gastrointestinal Toxicity and Immunocompetent Organic Toxicity Induced by 5‐Fluorouracil without Loss of Antitumor Activity in Mice
por: Kimura, Yoshiyuki, et al.
Publicado: (1999)

Evaluation of body-surface-area adjusted dosing of high-dose methotrexate by population pharmacokinetics in a large cohort of cancer patients
por: Arshad, Usman, et al.
Publicado: (2021)

Analytical approaches to the study of the disposition of myelotoxic agents.
por: Rickert, D E, et al.
Publicado: (1981)

Genetic differences in susceptibility to chemically induced myelotoxicity and leukemia.
por: Nebert, D W
Publicado: (1981)

Azathioprine-induced Myelotoxicity After Switching Mesalazine Compound
por: Barnhoorn, Marieke C, et al.
Publicado: (2021)

Azathioprine: Tuberculous perihepatic abscess and myelotoxicity: case report
Publicado: (2021)

Prevention of benzene-induced myelotoxicity by nonsteroidal anti-inflammatory drugs.
por: Kalf, G F, et al.
Publicado: (1989)

Importance of Starting Age for Myelotoxicity Study in Dietary Restricted Rats
por: Asanuma, Fumiko, et al.
Publicado: (2009)

Evaluation of Short-term Myelotoxicity Study in Dietary Reduced Rats
por: Asanuma, Fumiko, et al.
Publicado: (2010)

The frequency of hepatotoxicity and myelotoxicity in leukemic children with different high doses of methotrexate
por: Özdemir, Zeynep Canan, et al.
Publicado: (2016)

Aqueous extract of Phragmitis rhizoma ameliorates myelotoxicity of docetaxel in vitro and in vivo
por: Kim, Jinhee, et al.
Publicado: (2017)

Chlorella sorokiniana Extract Prevents Cisplatin-Induced Myelotoxicity In Vitro and In Vivo
por: Lin, Shyh-Horng, et al.
Publicado: (2020)

Influence of the skeletal muscle index on pharmacokinetics and toxicity of fluorouracil
por: Schmulenson, Eduard, et al.
Publicado: (2022)

Impact of NUDT15 polymorphisms on thiopurines-induced myelotoxicity and thiopurines tolerance dose
por: Yin, Dandan, et al.
Publicado: (2017)

Myelotoxicity of Temozolomide Treatment in Patients with Glioblastoma Is It Time for a More Mechanistic Approach?
por: Said, Medhat M., et al.
Publicado: (2023)

Effect of Ketorolac on Pharmacokinetics and Pharmacodynamics of 5-Fluorouracil: In Vivo and In Vitro Study
por: Atefinezhad, Motahare, et al.
Publicado: (2022)

Intratibial injection of an anti-doxorubicin monoclonal antibody prevents drug-induced myelotoxicity in mice.
por: Morelli, D., et al.
Publicado: (1997)

Effects of varying the interval between courses of methotrexate on its myelotoxic and anti-leukaemic activities.
por: Harding, B., et al.
Publicado: (1977)

Avidin Chase Can Reduce Myelotoxicity Associated with Radioimmunotherapy of Experimental Liver Micrometastases in Mice
por: Sato, Noriko, et al.
Publicado: (2000)

Predicted expression of genes involved in the thiopurine metabolic pathway and azathioprine discontinuation due to myelotoxicity
por: Daniel, Laura L., et al.
Publicado: (2022)

Benzene-induced myelotoxicity: application of flow cytofluorometry for the evaluation of early proliferative change in bone marrow.
por: Irons, R D
Publicado: (1981)

Population Pharmacokinetics and Pharmacodynamics of Linagliptin in Patients with Type 2 Diabetes Mellitus
por: Retlich, Silke, et al.
Publicado: (2015)

Pharmacokinetics and pharmacodynamics of locoregional 5 fluorouracil (5FU) in advanced colorectal liver metastases.
por: Goldberg, J. A., et al.
Publicado: (1988)

Idarubicinol myelotoxicity: a comparison of in vitro data with clinical outcome in patients treated with high-dose idarubicin
por: Corsini, C, et al.
Publicado: (2000)

Myelotoxicity induced in female B6C3F1 mice by inhalation of methyl isocyanate.
por: Hong, H L, et al.
Publicado: (1987)

Association of thiopurine S-methyltransferase and NUDT15 polymorphisms with azathioprine-induced myelotoxicity in Chinese patients with rheumatological disease
por: Su, Song-Sen, et al.
Publicado: (2020)

Meta-Analysis of Same-Day Pegfilgrastim Administration Stratified by Myelotoxic Febrile Neutropenia Risk and Tumor Type
por: Alrawashdh, Neda, et al.
Publicado: (2022)

P1372: NON-MYELOTOXIC CHEMICALS AS A PREPARATORY REGIMEN FOR HEMATOPOIETIC STEM CELL GENE THERAPY
por: Emİn Şeker, Mehmet, et al.
Publicado: (2023)

Translational Pharmacokinetic‐Pharmacodynamic Modeling and Simulation: Optimizing 5‐Fluorouracil Dosing in Children With Pediatric Ependymoma
por: Daryani, VM, et al.
Publicado: (2016)

Brain Exposure to Piperacillin in Acute Hemorrhagic Stroke Patients Assessed by Cerebral Microdialysis and Population Pharmacokinetics
por: Ullah, Sami, et al.
Publicado: (2020)

TPMT*3C as a Predictor of 6-Mercaptopurine-Induced Myelotoxicity in Thai Children with Acute Lymphoblastic Leukemia
por: Jantararoungtong, Thawinee, et al.
Publicado: (2021)

Optimization of blood pressure measurement practices for pharmacodynamic analyses of tyrosine‐kinase inhibitors
por: Centanni, Maddalena, et al.
Publicado: (2022)

Pharmacokinetics and pharmacodynamics of moist inhalation epinephrine using a mobile inhaler
por: Breuer, C., et al.
Publicado: (2013)

THRB Genetic Polymorphisms Can Predict Severe Myelotoxicity after Definitive Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma
por: Miki, Ikuya, et al.
Publicado: (2012)

Diurnal expression of MRP4 in bone marrow cells underlies the dosing-time dependent changes in the oxaliplatin-induced myelotoxicity
por: Kato, Mizuki, et al.
Publicado: (2020)

Germline polymorphisms in MGMT associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825
por: Scheurer, Michael E, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ieiui3dnlcl4itpqds93an501n